How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research JAS Diagnostics Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
20 clearance records and 3 recall records in the covered releases, across 1 source company names and 21 product codes. Dated history runs from Dec 5, 2000 to Apr 21, 2017.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Drew Scientific DREW 3-PAC Reagent Kit containing: 5L Diluent, 750 mL Enzymatic Cleaner, and 125 mL Lysing Reagent.Z-2656-2017 · GKZ | JAS Diagnostics Inc. | Recall | Jun 30, 2017FDA record creation date |
| Glucose Hexokinase (Liquid) Reagent For the in vitro quantitative determination of Glucose in serum.Z-0827-2015 · CFR | JAS Diagnostics Inc. | Recall | Dec 18, 2014FDA classification date |
| Glucose Hexokinase Liquid Reagent For the in vitro quantitative determination of Glucose in serum.Z-1873-2014 · CGA | JAS Diagnostics Inc. | Recall | Jun 25, 2014FDA classification date |
| XL-200 CLINICAL CHEMISTRY ANALYZER, JAS GLUCOSE REAGENT, ISE REAGENT PACKK130915 · JJE | Jas Diagnostics, Inc. | 510(k) | May 15, 2014FDA decision date |
| CHOLESTEROL OXIDASE JASE, AND GLYCEROL INASE TRIGLYCERIDES, MODEL NAK080623 · CHH | Jas Diagnostics, Inc. | 510(k) | Nov 17, 2008FDA decision date |
| DIRECT HBA1C, FRUCTOSAMINE, GLUCOSE OXIDASE LIQUIDK080618 · LCP | Jas Diagnostics, Inc. | 510(k) | May 23, 2008FDA decision date |
| LDL CHOLESTEROL (AUTOMATED)K022519 · JHM | Jas Diagnostics, Inc. | 510(k) | Sep 30, 2002FDA decision date |
| JAS HDL CHOLESTEROL (AUTOMATED) REAGENTK021671 · LBS | Jas Diagnostics, Inc. | 510(k) | Jul 19, 2002FDA decision date |
| CHEMISTRY CALIBRATORK020454 · JIT | Jas Diagnostics, Inc. | 510(k) | Apr 8, 2002FDA decision date |
| JAS AMYLASE LIQUID REAGENTK020282 · JFJ | Jas Diagnostics, Inc. | 510(k) | Feb 28, 2002FDA decision date |
| CREATINE KINASE (CK-NAC)K013912 · CGS | Jas Diagnostics, Inc. | 510(k) | Jan 18, 2002FDA decision date |
| AST (SGOT)K013698 · CIT | Jas Diagnostics, Inc. | 510(k) | Dec 21, 2001FDA decision date |
| JAS CARBON DIOXIDE LIQUID REAGENTK012332 · KHS | Jas Diagnostics, Inc. | 510(k) | Sep 6, 2001FDA decision date |
| JAS URIC ACID LIQUID REAGENTK012038 · KNK | Jas Diagnostics, Inc. | 510(k) | Aug 21, 2001FDA decision date |
| GLUCOSE (HEXOKINASE)K011900 · CFR | Jas Diagnostics, Inc. | 510(k) | Jul 31, 2001FDA decision date |
| ALKALINE PHOSPHATASE LIQUID REAGENTK011599 · CJE | Jas Diagnostics, Inc. | 510(k) | Jul 20, 2001FDA decision date |
| JAS CALCIUM (ARSENAZO) REAGENTK011441 · CJY | Jas Diagnostics, Inc. | 510(k) | Jul 9, 2001FDA decision date |
| JAS MAGNESIUM REAGENTK003835 · JGJ | Jas Diagnostics, Inc. | 510(k) | Mar 23, 2001FDA decision date |
| PHOSPHORUS REAGENTK003912 · CEO | Jas Diagnostics, Inc. | 510(k) | Feb 21, 2001FDA decision date |
| TOTAL BILIRUBINK003829 · CIG | Jas Diagnostics, Inc. | 510(k) | Feb 12, 2001FDA decision date |
| DIRECT BILIRUBINK003693 · CIG | Jas Diagnostics, Inc. | 510(k) | Jan 29, 2001FDA decision date |
| CREATININEK003247 · CGX | Jas Diagnostics, Inc. | 510(k) | Dec 14, 2000FDA decision date |
| ALBUMINK003327 · CIX | Jas Diagnostics, Inc. | 510(k) | Dec 5, 2000FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.